Thursday, August 19, 2021 Daily Archives

Biotage triples lipid capacity to support mRNA vaccines

by

Demand for lipid nanoparticles for mRNA vaccines has driven Biotage to open a facility at its site in Cardiff, UK.   The facility, of which financial details have not been disclosed, sees Swedish separations firm Biotage expand its manufacturing capacity of large-scale flash columns by 300 percent, specifically to support companies and contract manufacturers scaling-up lipid production for COVID-19 vaccines.   “[Cardiff] is our largest site with capacity and competence for complicated and advanced column filling operations and [it is] geographically close to major customers,†Tomas Blomquist CEO of Biotage told BioProcess Insider. According to the firm, the shortage of raw materials for messenger RNA (mRNA) vaccine manufacturing…

August 19, 2021

M&A rife in manufacturing space, driven by big CDMOs and PE

by

The CDMO space is perceived as fragmented and particularly lucrative says GlobalData, with private equity (PE) firms and large established players investing heavily in the sector. A report from data and analytics company GlobalData entitled ‘M&A in the Contract Manufacturing Industry: Implications and Outlook – 2021 Edition’ has found that dealmaking in the sector has been particularly rife over the past few years, predominantly led by PE firms and big contract manufacturing organizations (CMOs). “Investors perceive the CMO industry as…

August 19, 2021